Svp, Global Business Development, Portfolio Management, Business Intelligence & Biosimilars
Dublin, Coolock, Ie
Held a series of roles with expanding responsibilities during the transformation of the company from Watson Labs, to Actavis, to Allergan. Built a leading portfolio of >300 new product opportunities, including many high-value first-to-market PIV patent challenges. Executed on licensing deals with worldwide partners to build a pipeline for commercial operations in more than 80 countries, while supporting an aggressive M&A agenda that executed over $100 Billion in transactions.